Dimensional Fund Advisors
IMNM icon

Dimensional Fund Advisors’s Immunome IMNM Stock Holding History

Dimensional Fund Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$731K Sell
33,408
-282,975
-89% -$6.3M ﹤0.01% 2892
2025
Q4 		$6.8M Sell
316,383
-21,972
-6% -$386K ﹤0.01% 2427
2025
Q3 		$3.96M Buy
338,355
+233,571
+223% +$2.32M ﹤0.01% 2606
2025
Q2 		$974K Buy
+104,784
New +$859K ﹤0.01% 2892
2024
Q1 		– Sell
-14,054
Closed -$150K – 3417
2023
Q4 		$150K Sell
14,054
-1,379
-9% -$11.5K ﹤0.01% 3234
2023
Q3 		$129K Hold
15,433
– – ﹤0.01% 3285
2023
Q2 		$122K Hold
15,433
– – ﹤0.01% 3301
2023
Q1 		$77K Buy
+15,433
New +$75.5K ﹤0.01% 3341

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Dimensional Fund Advisors's IMNM Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Immunome (IMNM) stake by 89% in Q1 2026, selling an estimated $6.3M and leaving 33,408 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Dimensional Fund Advisors first reported a position in IMNM in Q1 2023 and has held it in 8 quarters since. The position peaked at $6.8M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Dimensional Fund Advisors held 33,408 shares of Immunome worth $731K as of Q1 2026.
  • Dimensional Fund Advisors sold 282,975 Immunome shares in Q1 2026, an estimated $6.3M.
  • Immunome made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2892 holding.
  • Dimensional Fund Advisors first reported a position in Immunome in Q1 2023 and has held it in 8 quarters since.
  • Dimensional Fund Advisors's Immunome position peaked at $6.8M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.